CP

Chimanlal Purushottamdas Patel - Profile

Chimanlal Purushottamdas Patel, Director and Additional Director, with 11 companies.

About Chimanlal Purushottamdas Patel

Chimanlal Purushottamdas Patel has 7 years in corporate governance. Holds Director and Additional Director roles. Currently with 7 companies, including German Remedies Pharmaceuticals Private Limited and Zydus Animal Health And Investments Limited. Formerly with 4 companies, such as Zydus Animal Health And Investments Limited and German Remedies Pharmaceuticals Private Limited. Engaged in General Business, Healthcare.

Current Companies 7
Past Companies 4
Total Affiliations 11
Oldest Company Age 20
Companies Associated with Chimanlal Purushottamdas Patel
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Chimanlal Purushottamdas Patel?

Chimanlal Purushottamdas Patel has 7 years in corporate governance. Holds Director and Additional Director roles. Currently with 7 companies, including German Remedies Pharmaceuticals Private Limited and Zydus Animal Health And Investments Limited. Formerly with 4 companies, such as Zydus Animal Health And Investments Limited and German Remedies Pharmaceuticals Private Limited. Engaged in General Business, Healthcare.

What is Chimanlal Purushottamdas Patel's role in current companies?

Chimanlal Purushottamdas Patel is associated with 7 companies as Director and Additional Director.

What industries does Chimanlal Purushottamdas Patel specialize in?

Chimanlal Purushottamdas Patel has expertise in General Business, Healthcare.

How many years of experience does Chimanlal Purushottamdas Patel have?

Chimanlal Purushottamdas Patel has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available